At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 29 enrolled
Drug / intervention
Vaccinebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Immunogenicity of an Intradermal Qdenga Vaccine Among Healthy Volunteers: A Pilot Study
In Brief
A Early Phase 1 clinical trial evaluating Vaccine for Dengue. Completed, enrolled 29 participants across 2 sites.
Detailed Summary
Official title: Immunogenicity of an intradermal Qdenga vaccine among healthy volunteers: A pilot study
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDengue
CountriesThailand
Collaborators--
Timeline
Early Ph 1CompletedFinished
2026
First PostedFeb 2025
Enrollment StartApr 2025
Primary CompletionAug 2025
Study CompletionSep 2025
TodayJul 2026
First PostedFeb 20, 2025
Enrollment StartApr 19, 2025
Primary CompletionAug 30, 2025
Study CompletionSep 30, 2025
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 1.4 years ago
Interventions
Vaccinebiological
Subcutaneous route vs Intradermal route